NEW DELHI: The government has decided to draw up a list of serious and life-threatening diseases, and ailments that are particularly relevant to India, for which a new drug can be considered for exemption from local clinical trials if it has already been approved and marketed safely in developed countries such as the United States, UK, Canada, Japan and Australia.
The decision, officials said, was taken at a recent meeting of the technical committee set up under the health ministry t ..
The decision, officials said, was taken at a recent meeting of the technical committee set up under the health ministry t ..
No comments:
Post a Comment